News

Dr. Nadine Caron has been inducted into the Canadian Medical Hall of Fame in recognition of her transformative leadership in Indigenous health and surgical practice.

Dr. Caron is a senior scientist with BC Cancer’s Genome Sciences Centre, co-director of the UBC Centre for Excellence in Indigenous Health and a professor in UBC’s department of surgery and Northern Medical Program, which is delivered in partnership with the University of Northern British Columbia. 

Congratulations to the recipients of the BC Cancer Foundation (BCCF) 2024 Rising Stars Award competition!

This year’s awardees are: 

BC Cancer researchers receive Cancer Research Society’s Doctoral Research Awards

Three BC Cancer graduate students are 2024 recipients of Doctoral Research Awards from the Cancer Research Society (CRS), receiving new funding to support their innovative research aimed at better understanding cancer.

Doctoral Research Awards recipients 

BC Cancer’s 2024 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.

2024 Emerging Multidisciplinary Research Programs Recipients: 

Researchers at BC Cancer, the University of British Columbia (UBC), Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early genetic origins of breast cancer—cancer-like mutations appearing in the cells of healthy women.

Dr. Poul Sorensen is the recipient of the 2024 Doctors of BC Terry Fox Medal, a prestigious award recognizing outstanding individuals who have achieved success in clinical practice, research and/or teaching to advance cancer care. A distinguished scientist at the BC Cancer Research Institute (BCCRI) and professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia (UBC), Dr. Sorensen was selected based on his remarkable contributions to the field of pediatric cancer research and in translating scientific discoveries into clinical practice.